Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group.
Strijker M, Mackay TM, Bonsing BA, Bruno MJ, van Eijck CHJ, de Hingh IHJT, Koerkamp BG, van Laarhoven HW, Molenaar IQ, van Santvoort HC, van Tienhoven G, Wilmink JW, Zeverijn S, Busch OR, Besselink MG; Dutch Pancreatic Cancer Group. Strijker M, et al. Among authors: van santvoort hc, van laarhoven hw, van tienhoven g, van eijck chj. Ann Surg. 2020 Apr;271(4):e102-e104. doi: 10.1097/SLA.0000000000003779. Ann Surg. 2020. PMID: 32084037 No abstract available.
Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
Morak MJ, Richel DJ, van Eijck CH, Nuyttens JJ, van der Gaast A, Vervenne WL, Padmos EE, Schaake EE, Busch OR, van Tienhoven G. Morak MJ, et al. Among authors: van eijck ch, van tienhoven g, van der gaast a. Radiother Oncol. 2011 Feb;98(2):261-4. doi: 10.1016/j.radonc.2010.10.016. Epub 2010 Nov 12. Radiother Oncol. 2011. PMID: 21075468 Clinical Trial.
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, De Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L. Bonnetain F, et al. Among authors: van laethem jl, van tienhoven g. Eur J Cancer. 2014 Nov;50(17):2983-93. doi: 10.1016/j.ejca.2014.07.011. Epub 2014 Sep 22. Eur J Cancer. 2014. PMID: 25256896 Review.
Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.
Klaassen R, Bennink RJ, van Tienhoven G, Bijlsma MF, Besselink MG, van Berge Henegouwen MI, Wilmink JW, Nederveen AJ, Windhorst AD, Hulshof MC, van Laarhoven HW. Klaassen R, et al. Among authors: van laarhoven hw, van tienhoven g, van berge henegouwen mi. Radiother Oncol. 2015 Jul;116(1):94-9. doi: 10.1016/j.radonc.2015.05.009. Epub 2015 Jun 3. Radiother Oncol. 2015. PMID: 26049919 Free article.
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer.
van Zweeden AA, van der Vliet HJ, Wilmink JW, Meijerink MR, Meijer OW, Bruynzeel AM, van Tienhoven G, Giovannetti E, Kazemier G, Jacobs MA, Verheul HM. van Zweeden AA, et al. Among authors: van der vliet hj, van tienhoven g. Clin Cancer Res. 2015 Oct 15;21(20):4569-75. doi: 10.1158/1078-0432.CCR-14-3364. Epub 2015 Jun 8. Clin Cancer Res. 2015. PMID: 26056353 Clinical Trial.
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.
Versteijne E, van Eijck CH, Punt CJ, Suker M, Zwinderman AH, Dohmen MA, Groothuis KB, Busch OR, Besselink MG, de Hingh IH, Ten Tije AJ, Patijn GA, Bonsing BA, de Vos-Geelen J, Klaase JM, Festen S, Boerma D, Erdmann JI, Molenaar IQ, van der Harst E, van der Kolk MB, Rasch CR, van Tienhoven G; Dutch Pancreatic Cancer Group (DPCG). Versteijne E, et al. Among authors: van der kolk mb, van eijck ch, van der harst e, van tienhoven g. Trials. 2016 Mar 9;17(1):127. doi: 10.1186/s13063-016-1262-z. Trials. 2016. PMID: 26955809 Free PMC article. Clinical Trial.
Oncologists' non-verbal behavior and analog patients' recall of information.
Hillen MA, de Haes HC, van Tienhoven G, van Laarhoven HW, van Weert JC, Vermeulen DM, Smets EM. Hillen MA, et al. Among authors: van weert jc, van laarhoven hw, van tienhoven g. Acta Oncol. 2016 Jun;55(6):671-9. doi: 10.3109/0284186X.2015.1120884. Epub 2016 Mar 31. Acta Oncol. 2016. PMID: 27031166 Free article.
Quantitative assessment of biliary stent artifacts on MR images: Potential implications for target delineation in radiotherapy.
Gurney-Champion OJ, Bruins Slot T, Lens E, van der Horst A, Klaassen R, van Laarhoven HW, van Tienhoven G, van Hooft JE, Nederveen AJ, Bel A. Gurney-Champion OJ, et al. Among authors: van hooft je, van laarhoven hw, van der horst a, van tienhoven g. Med Phys. 2016 Oct;43(10):5603. doi: 10.1118/1.4962476. Med Phys. 2016. PMID: 27782717
195 results